UNSPSC 51286402: Pecocycline

This classification denotes an antibiotic with the molecular formula C29H35N3O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0CG6O25ZC4, chemically known as n-((4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacene carboxamido)-methyl)nipecotic acid but more generally known as pecocycline, which bears US NIH Compound Identifier 5745800. European Medicines Agency schedules Pecocycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09644MIG.

The term PECOCYCLINE is an International Non-Proprietary Name. PECOCYCLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OC12C(CC3C(O)(C4C(C(=C3C1=O)O)C(O)CCC4)C)C(N(C)C)C(=O)C(=C(\O)NCN1CC(CCC1)C(=O)O)\C2=O.

UNSPSC 51286402 Pecocycline, a Commodity code, reflects state and local procurement of pharmaceutical products and medical supplies for public health and emergency response programs. Recent solicitations show governments buying naloxone and drug deactivation systems for community health initiatives, medical and first aid supplies for fire rescue operations, generic pharmaceuticals and over-the-counter products through cooperative purchasing arrangements, and direct-to-manufacturer prescription programs to improve fulfillment efficiency and cost management. The issuing bodies span county health departments, municipal fire departments, state health and human services agencies, and regional cooperative purchasing alliances serving multiple jurisdictions.

Activity under the code is geographically dispersed across Florida, Texas, Minnesota, and Oregon, with county, city, state, and multi-state cooperative vehicles all active. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline; the City of Tampa's IFB 26P00145 for medical and first aid supplies (169 line items, estimated $700,000.00) with a March 13, 2026 due date and a 5% bid discount for certified Small Local Business Enterprises; the Texas Health and Human Services Commission's RFI HHS0017013 on direct-to-manufacturer prescription programs, posted April 3, 2026; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, with awards effective July 1, 2026 and extending through June 30, 2028 for incumbent vendors.